Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
AnaptysBio, Inc. (ANAB) had Receiveable Turnover of 2.50 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$17.16M |
|
$-163.62M |
|
-- |
|
$17.16M |
|
$181.57M |
|
$-164.41M |
|
$0.79M |
|
$-163.62M |
|
$-163.62M |
|
$-163.62M |
|
$-163.62M |
|
$-163.62M |
|
$-163.62M |
|
$-164.41M |
|
$-172.56M |
|
26.92M |
|
26.92M |
|
$-6.08 |
|
$-6.08 |
|
| Balance Sheet Financials | |
$406.83M |
|
$2.10M |
|
$45.55M |
|
$452.39M |
|
$37.44M |
|
-- |
|
$326.84M |
|
$364.29M |
|
$88.10M |
|
$88.10M |
|
$88.10M |
|
26.60M |
|
| Cash Flow Statement Financials | |
$-120.80M |
|
$144.75M |
|
$-59.30M |
|
$71.31M |
|
$35.97M |
|
$-35.34M |
|
$33.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-958.27% |
|
-958.27% |
|
-1005.75% |
|
-953.68% |
|
-953.66% |
|
$-121.61M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
|
Receiveable Turnover |
2.50 |
145.75 |
|
-185.71% |
|
-185.71% |
|
-36.17% |
|
-185.71% |
|
$3.31 |
|
$-4.52 |
|
$-4.49 |
|